Is rapid treatment of depression on the horizon with GABA-NAMs?

Written by Emily Brown

New preclinical findings have identified novel compounds that may hold the potential to treat depression in less than 24 hours. The study, published recently in Neuropsychopharmacology, presents a potential new avenue for faster treatment of depression with fewer side effects. “Our results open up a whole new class of potential antidepressant medications,” commented lead researcher Scott Thompson from the University of Maryland School of Medicine (MD, USA). “We have evidence that these compounds can relieve the devastating symptoms of depression in less than 1 day, and can do so in a way that limits some of the key disadvantages of...

To view this content, please register now for access

It's completely free